$PLUR
Pluri Inc. Stock $plur

$plur Overview Financials Valuation SEC Filings Company Website

2014 Q4 Form 10-Q Financial Statement

#000117891314003396 Filed on November 06, 2014

Income Statement

Concept	2014 Q4	2014 Q3	2013 Q3
Revenue	$95.00K	$95.00K	$95.00K
YoY Change	0.0%	0.0%	-51.28%
Cost Of Revenue	$4.000K	$3.000K	$3.000K
YoY Change	33.33%	0.0%	-50.0%
Gross Profit	$91.00K	$92.00K	$92.00K
YoY Change	-1.09%	0.0%	-51.32%
Gross Profit Margin	95.79%	96.84%	96.84%
Selling, General & Admin	$1.510M	$1.680M	$1.830M
YoY Change	-23.74%	-8.2%	8.93%
% of Gross Profit	1659.34%	1826.09%	1989.13%
Research & Development	$5.385M		$5.497M
YoY Change	-11.82%		46.66%
% of Gross Profit	5917.58%		5975.0%
Depreciation & Amortization	$500.0K	$498.0K	$461.0K
YoY Change	4.17%	8.03%	254.62%
% of Gross Profit	549.45%	541.3%	501.09%
Operating Expenses	$5.385M	$5.720M	$4.952M
YoY Change	-11.82%	15.51%	13.09%
Operating Profit	-$6.301M	-$5.623M	-$4.860M
YoY Change	-9.86%	15.7%	15.99%
Interest Expense	$60.00K	$200.0K	$110.0K
YoY Change	-79.31%	81.82%	-45.0%
% of Operating Profit
Other Income/Expense, Net	$56.00K	-$288.0K	$105.0K
YoY Change	-80.35%	-374.29%
Pretax Income	-$6.250M	-$5.910M	-$4.760M
YoY Change	-6.86%	24.16%	19.0%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$6.245M	-$5.911M	-$4.755M
YoY Change	-6.86%	24.31%	19.02%
Net Earnings / Revenue	-6573.68%	-6222.11%	-5005.26%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.89	-$0.86	-$0.80
COMMON SHARES
Basic Shares Outstanding	70.08M shares	69.28M shares	59.18M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q4	2014 Q3	2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$45.24M	$46.05M	$48.67M
YoY Change	-20.28%	-5.38%	-28.75%
Cash & Equivalents	$6.961M	$5.662M	$8.603M
Short-Term Investments	$38.28M	$40.39M	$40.06M
Other Short-Term Assets	$1.040M	$704.0K	$3.049M
YoY Change	-13.19%	-76.91%
Inventory
Prepaid Expenses
Receivables	$158.0K	$451.0K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$47.13M	$52.29M	$52.47M
YoY Change	-19.29%	-0.34%	-25.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.20M	$10.54M	$11.66M
YoY Change	-10.89%	-9.62%	81.1%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$270.0K	$290.0K	$310.0K
YoY Change	-15.63%	-6.45%	-68.37%
Other Assets	$9.000K	$2.000K	$21.00K
YoY Change	-65.38%	-90.48%	-99.39%
Total Long-Term Assets	$11.21M	$11.54M	$13.02M
YoY Change	-13.32%	-11.35%	13.55%
TOTAL ASSETS
Total Short-Term Assets	$47.13M	$52.29M	$52.47M
Total Long-Term Assets	$11.21M	$11.54M	$13.02M
Total Assets	$58.34M	$63.83M	$65.48M
YoY Change	-18.21%	-2.52%	-19.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.522M	$2.421M	$2.880M
YoY Change	-6.97%	-15.94%	69.81%
Accrued Expenses	$677.0K	$1.003M	$1.003M
YoY Change	-24.94%	0.0%	-6.17%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.173M	$5.985M	$5.731M
YoY Change	-7.28%	4.43%	9.54%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$544.0K	$566.0K	$657.0K
YoY Change	-14.06%	-13.85%	-83.66%
Total Long-Term Liabilities	$4.028M	$4.150M	$4.961M
YoY Change	-18.05%	-16.35%	23.44%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.173M	$5.985M	$5.731M
Total Long-Term Liabilities	$4.028M	$4.150M	$4.961M
Total Liabilities	$9.201M	$10.14M	$10.69M
YoY Change	-12.32%	-5.21%	15.58%
SHAREHOLDERS EQUITY
Retained Earnings	-$126.0M	-$119.7M	-$91.66M
YoY Change	28.09%	30.64%	31.42%
Common Stock	$0.00	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$49.14M	$53.70M	$54.79M
YoY Change
Total Liabilities & Shareholders Equity	$58.34M	$63.83M	$65.48M
YoY Change	-18.21%	-2.52%	-19.6%

Cashflow Statement

Concept	2014 Q4	2014 Q3	2013 Q3
OPERATING ACTIVITIES
Net Income	-$6.245M	-$5.911M	-$4.755M
YoY Change	-6.86%	24.31%	19.02%
Depreciation, Depletion And Amortization	$500.0K	$498.0K	$461.0K
YoY Change	4.17%	8.03%	254.62%
Cash From Operating Activities	-$5.570M	-$3.460M	-$5.095M
YoY Change	85.05%	-32.09%	44.66%
INVESTING ACTIVITIES
Capital Expenditures	$280.0K	$271.0K	$462.0K
YoY Change	-60.56%	-41.34%	-76.64%
Acquisitions
YoY Change
Other Investing Activities	$6.480M	$4.790M	$3.000K
YoY Change	-804.35%	159566.67%	-101.0%
Cash From Investing Activities	$6.200M	$4.520M	$4.182M
YoY Change	-480.37%	8.08%	-260.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	660.0K	110.0K	$509.0K
YoY Change	-1.49%	-78.39%	-98.57%
NET CHANGE
Cash From Operating Activities	-5.570M	-3.460M	-$5.095M
Cash From Investing Activities	6.200M	4.520M	$4.182M
Cash From Financing Activities	660.0K	110.0K	$509.0K
Net Change In Cash	1.290M	1.170M	-$404.0K
YoY Change	-132.49%	-389.6%	-101.38%
FREE CASH FLOW
Cash From Operating Activities	-$5.570M	-$3.460M	-$5.095M
Capital Expenditures	$280.0K	$271.0K	$462.0K
Free Cash Flow	-$5.850M	-$3.731M	-$5.557M
YoY Change	57.26%	-32.86%	1.04%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	105000	USD
CY2014Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	70078391	shares
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2014Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	69585642	shares
CY2014Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	68601452	shares
CY2014Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2014Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	451000	USD
CY2014Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2263000	USD
CY2014Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2014Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2014Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	69585642	shares
CY2014Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	68601452	shares
CY2014Q2	us-gaap	Common Stock Value CommonStockValue		USD
CY2014Q2	us-gaap	Short Term Investments ShortTermInvestments	19451000	USD
CY2014Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	5083000	USD
CY2014Q3	us-gaap	Stockholders Equity StockholdersEquity	53695000	USD
CY2014Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	2391000	USD
CY2014Q2	us-gaap	Assets Current AssetsCurrent	61987000	USD
CY2014Q3	us-gaap	Long Term Investments LongTermInvestments	289000	USD
CY2014Q2	us-gaap	Long Term Investments LongTermInvestments	304000	USD
CY2014Q3	us-gaap	Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent	706000	USD
CY2014Q2	us-gaap	Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent	901000	USD
CY2014Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	63830000	USD
CY2014Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	74023000	USD
CY2014Q3	us-gaap	Common Stock Value CommonStockValue		USD
CY2014Q3	us-gaap	Short Term Investments ShortTermInvestments	14494000	USD
CY2014Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	172998000	USD
CY2014Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-119745000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4493000	USD
CY2014Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-113834000	USD
CY2014Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2959000	USD
CY2014Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	566000	USD
CY2014Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	588000	USD
CY2014Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4150000	USD
CY2014Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4503000	USD
CY2014Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	174169000	USD
CY2014Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5985000	USD
CY2014Q2	us-gaap	Liabilities Current LiabilitiesCurrent	7397000	USD
CY2014Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2752000	USD
CY2014Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2847000	USD
CY2014Q3	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	832000	USD
CY2014Q2	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	1068000	USD
CY2014Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	379000	USD
CY2014Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	379000	USD
CY2014Q3	us-gaap	Customer Advances Current CustomerAdvancesCurrent	218000	USD
CY2014Q2	us-gaap	Customer Advances Current CustomerAdvancesCurrent	247000	USD
CY2014Q3	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1964000	USD
CY2014Q3	us-gaap	Assets Assets	63830000	USD
CY2014Q2	us-gaap	Assets Assets	74023000	USD
CY2014Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2421000	USD
CY2014Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3465000	USD
CY2014Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1003000	USD
CY2014Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	915000	USD
CY2014Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10541000	USD
CY2014Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10823000	USD
CY2014Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2000	USD
CY2014Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8000	USD
CY2014Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	11538000	USD
CY2014Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	12036000	USD
CY2014Q3	us-gaap	Assets Current AssetsCurrent	52292000	USD
CY2014Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	4914000	USD
CY2014Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	25898000	USD
CY2014Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	29961000	USD
CY2014Q3	us-gaap	Other Assets Current OtherAssetsCurrent	704000	USD
CY2014Q2	us-gaap	Other Assets Current OtherAssetsCurrent	905000	USD
CY2014Q3	us-gaap	Revenues Revenues	95000	USD
CY2013Q3	us-gaap	Revenues Revenues	95000	USD
CY2014Q3	us-gaap	Cost Of Revenue CostOfRevenue	3000	USD
CY2013Q3	us-gaap	Cost Of Revenue CostOfRevenue	3000	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	92000	USD
CY2013Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	59254132	shares
CY2014Q3	us-gaap	Income Taxes Paid IncomeTaxesPaid	30000	USD
CY2013Q3	us-gaap	Income Taxes Paid IncomeTaxesPaid	31000	USD
CY2014Q3	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	188000	USD
CY2013Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	537000	USD
CY2013Q3	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	668000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1169000	USD
CY2013Q3	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-404000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9007000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5662000	USD
CY2014Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.09
CY2013Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
CY2014Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	69131435	shares
CY2013Q3	psti	Research And Development Expenses Net ResearchAndDevelopmentExpensesNet	3123000	USD
CY2014Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1678000	USD
CY2013Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1829000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5623000	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4860000	USD
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-288000	USD
CY2013Q3	us-gaap	Gross Profit GrossProfit	92000	USD
CY2013Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4360000	USD
CY2013Q3	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax		USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-455000	USD
CY2013Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	142000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3688000	USD
CY2013Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	395000	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9599000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-133000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-4010000	USD
CY2014Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1060000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3688000	USD
CY2014Q3	psti	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	2000	USD
CY2014Q3	psti	Stock Issued During Period Value Stock Warrants Exercised StockIssuedDuringPeriodValueStockWarrantsExercised	109000	USD
CY2013Q3	us-gaap	Stockholders Equity StockholdersEquity	54791000	USD
CY2014Q2	us-gaap	Stockholders Equity StockholdersEquity	62123000	USD
CY2013Q3	psti	Stock Issued During Period Value Stock Warrants Exercised StockIssuedDuringPeriodValueStockWarrantsExercised	509000	USD
CY2013Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1176000	USD
CY2013Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	395000	USD
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	57466000	USD
CY2014Q3	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	2000	USD
CY2013Q3	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1		USD
CY2014Q3	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	9000	USD
CY2013Q3	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet		USD
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8603000	USD
CY2014Q3	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	4516000	USD
CY2013Q3	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	4182000	USD
CY2014Q3	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	109000	USD
CY2013Q3	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	509000	USD
CY2014Q3	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	109000	USD
CY2013Q3	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	509000	USD
CY2014Q3	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	37000	USD
CY2013Q3	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	1870000	USD
CY2014Q3	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	64000	USD
CY2014Q3	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3456000	USD
CY2013Q3	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-5095000	USD
CY2014Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	271000	USD
CY2013Q3	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	394000	USD
CY2014Q3	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	92000	USD
CY2013Q3	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	4861000	USD
CY2014Q3	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-4777000	USD
CY2013Q3	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-7132000	USD
CY2014Q3	us-gaap	Payments For Proceeds From Longterm Investments PaymentsForProceedsFromLongtermInvestments	-1000	USD
CY2013Q3	us-gaap	Payments For Proceeds From Longterm Investments PaymentsForProceedsFromLongtermInvestments	3000	USD
CY2014Q3	us-gaap	Increase Decrease In Restricted Cash And Investments IncreaseDecreaseInRestrictedCashAndInvestments		USD
CY2013Q3	us-gaap	Increase Decrease In Restricted Cash And Investments IncreaseDecreaseInRestrictedCashAndInvestments	-112000	USD
CY2014Q3	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	-41000	USD
CY2013Q3	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	35000	USD
CY2013Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	462000	USD
CY2014Q3	psti	Linkage Differences And Interest On Short And Long Term Restricted Lease Deposit LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit	37000	USD
CY2013Q3	psti	Linkage Differences And Interest On Short And Long Term Restricted Lease Deposit LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit	-168000	USD
CY2014Q3	psti	Amortization Of Discount And Premium And Changes In Accrued Interest From Marketable Securities AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities	44000	USD
CY2013Q3	psti	Amortization Of Discount And Premium And Changes In Accrued Interest From Marketable Securities AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities	559000	USD
CY2014Q3	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-17000	USD
CY2013Q3	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	142000	USD
CY2014Q3	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-9000	USD
CY2013Q3	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	160000	USD
CY2014Q3	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-95000	USD
CY2013Q3	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-474000	USD
CY2014Q3	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-29000	USD
CY2013Q3	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-37000	USD
CY2014Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-333000	USD
CY2013Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	95000	USD
CY2014Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	174000	USD
CY2013Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	7000	USD
CY2014Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-989000	USD
CY2013Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	247000	USD
CY2014Q3	us-gaap	Depreciation Depreciation	498000	USD
CY2013Q3	us-gaap	Depreciation Depreciation	461000	USD
CY2014Q3	us-gaap	Share Based Compensation ShareBasedCompensation	1060000	USD
CY2013Q3	us-gaap	Share Based Compensation ShareBasedCompensation	1176000	USD
CY2014Q3	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-1812000	USD
CY2013Q3	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	2055000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-5911000	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-4755000	USD
CY2014Q3	us-gaap	Reimbursement Revenue ReimbursementRevenue	10000000	USD
CY2013Q4	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	2500000	shares
CY2013Q4	psti	Available For Sale Marketable Securities Number AvailableForSaleMarketableSecuritiesNumber	1011504	shares
CY2013Q4	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	10414000	USD
CY2014Q3	us-gaap	Available For Sale Equity Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1908000	USD
CY2014Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	25898000	USD
CY2011Q3	us-gaap	Licenses Revenue LicensesRevenue	7000000	USD
CY2011Q3	us-gaap	Revenue From Grants RevenueFromGrants	5000000	USD
CY2011Q3	us-gaap	Proceeds From Customers ProceedsFromCustomers	2000000	USD
CY2014Q3	psti	Research And Development Milestone Revenue Receivable ResearchAndDevelopmentMilestoneRevenueReceivable	37500000	USD
CY2014Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-729000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-4288000	USD
CY2014Q3	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-600000	USD
CY2013Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-7000	USD
CY2014Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-198000	USD
CY2014Q3	us-gaap	Use Of Estimates UseOfEstimates	<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"><div align="justify" style=" text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div><div class="CursorPointer"><table align="center" border="0" cellpadding="0" cellspacing="0" style=" font-size: 10pt; font-family : Times New Roman; width: 100%;"> <tr valign="top"> <td style=" border-left: none; border-right: none; border-top: none; border-bottom: none; width: 0%;"> <div> </div> </td> <td style=" border-left: none; border-right: none; border-top: none; border-bottom: none; width: 0%;"> <div style=" text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style=" display: inline; font-family : Times New Roman; font-size: 10pt;">c.</font></div> </td> <td style=" border-left: none; border-right: none; border-top: none; border-bottom: none;"> <div align="left"> <div align="left"><font style=" display: inline; font-family : Times New Roman; font-size: 10pt;"><font style=" font-style: italic; display: inline; font-size: 10pt; font-weight: bold;">Use of estimates</font></font></div> </div> </td> </tr> </table></div> </div> </div> <div align="justify" style=" text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> </div> <div align="justify" style=" text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt;"><font style=" display: inline; font-family : Times New Roman; font-size: 10pt;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</font></div> <div align="justify" style=" text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> </div></div>
CY2014Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	452000	USD
CY2014Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	19000	USD
CY2014Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	851000	USD
CY2014Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	17000	USD
CY2014Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	463000	USD
CY2014Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	12000	USD
CY2014Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	27025000	USD
CY2014Q2	us-gaap	Available For Sale Equity Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2965000	USD
CY2014Q2	us-gaap	Available For Sale Equity Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax	29000	USD
CY2014Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	29961000	USD
CY2014Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	2336000	USD
CY2014Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	129000	USD
CY2014Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	26517000	USD
CY2014Q3	us-gaap	Available For Sale Equity Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1289000	USD
CY2014Q3	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	-701000	USD
CY2014Q2	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	-842000	USD
CY2014Q3	psti	Sharebased Goods And Nonemployees Services Transaction Warrants And Options Number SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber	252000	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.73
CY2014Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3000	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.62
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1859099	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	3.73
CY2014Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P2Y10M13D
CY2014Q2	psti	Warrants And Options Weighted Average Exercise Price WarrantsAndOptionsWeightedAverageExercisePrice	5.19
CY2014Q3	psti	Warrants And Options Aggregate Intrinsic Value Vested And Expected To Vest WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest	300000	USD
CY2014Q3	psti	Royalty Rate Payable On Grants Received RoyaltyRatePayableOnGrantsReceived	1.00	pure
CY2014Q3	psti	Aggregate Grants Received AggregateGrantsReceived	17406000	USD
CY2014Q3	psti	Royalties Amount Paid And Accrued RoyaltiesAmountPaidAndAccrued	57000	USD
CY2014Q3	us-gaap	Royalty Guarantees Commitments Amount RoyaltyGuaranteesCommitmentsAmount	17349000	USD
CY2014Q3	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	155000	USD
CY2014Q3	psti	Warrants And Options Weighted Average Exercise Price Excercisable WarrantsAndOptionsWeightedAverageExercisePriceExcercisable	5.19
CY2014Q3	psti	Warrants And Options Weighted Average Remaining Contractual Term Exercisable WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable	P3Y8M16D
CY2014Q3	psti	Warrants And Options Aggregate Intrinsic Value Exercisable WarrantsAndOptionsAggregateIntrinsicValueExercisable	300000	USD
CY2014Q3	psti	Sharebased Goods And Nonemployees Services Transaction Warrants And Options Number Vested And Expected To Vest SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest	252000	shares
CY2014Q3	psti	Warrants And Options Weighted Average Exercise Price Vested And Expected To Vest WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest	5.19
CY2014Q3	psti	Warrants And Options Weighted Average Remaining Contractual Term Vested And Expected To Vest WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest	P3Y8M16D
CY2014Q3	psti	Warrants And Options Weighted Average Exercise Price WarrantsAndOptionsWeightedAverageExercisePrice	5.19
CY2014Q3	psti	Warrants And Options Weighted Average Remaining Contractual Term WarrantsAndOptionsWeightedAverageRemainingContractualTerm	P3Y8M16D
CY2014Q3	psti	Warrants And Options Aggregate Intrinsic Value WarrantsAndOptionsAggregateIntrinsicValue	300000	USD
CY2014Q3	psti	Sharebased Goods And Nonemployees Services Transaction Warrants And Options Number Exercisable SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable	252000	shares
CY2014Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	929000	USD
CY2014Q3	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	929000	USD
CY2014Q2	psti	Sharebased Goods And Nonemployees Services Transaction Warrants And Options Number SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber	252000	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.73
CY2014Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y10M13D
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	929000	USD
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1859099	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.73
CY2014Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y10M13D
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1862099	shares
CY2014Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2014Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1859099	shares
CY2014Q3	dei	Entity Registrant Name EntityRegistrantName	PLURISTEM THERAPEUTICS INC
CY2014Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001158780
CY2014Q3	dei	Document Type DocumentType	10-Q
CY2014Q3	dei	Document Period End Date DocumentPeriodEndDate	2014-09-30
CY2014Q3	dei	Amendment Flag AmendmentFlag	false
CY2014Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30

Files In Submission

Name	View Source	Status
0001178913-14-003396-index-headers.html	Edgar Link	pending
0001178913-14-003396-index.html	Edgar Link	pending
0001178913-14-003396.txt	Edgar Link	pending
0001178913-14-003396-xbrl.zip	Edgar Link	pending
exhibit_31-1.htm	Edgar Link	pending
exhibit_31-2.htm	Edgar Link	pending
exhibit_32-1.htm	Edgar Link	pending
exhibit_32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
psti-20140930.xml	Edgar Link	completed
psti-20140930.xsd	Edgar Link	pending
psti-20140930_cal.xml	Edgar Link	unprocessable
psti-20140930_def.xml	Edgar Link	unprocessable
psti-20140930_lab.xml	Edgar Link	unprocessable
psti-20140930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zk1415726.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PLUR
Pluri Inc. Stock $plur

2014 Q4 Form 10-Q Financial Statement

#000117891314003396 Filed on November 06, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLUR Pluri Inc. Stock $plur

2014 Q4 Form 10-Q Financial Statement

#000117891314003396 Filed on November 06, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLUR
Pluri Inc. Stock $plur